Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

OBJECTIVES: Induction chemotherapy (ICT) followed by definitive treatment is an accepted non-surgical approach for locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, ICT remains a challenge for cisplatin-unfit patients. We evaluated paclitaxel and cetuximab (P-C) as I...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Jiménez, Juan A., Oliva, Marc, Peinado Martín, Paloma, Cabezas-Camarero, Santiago, Plana Serrahima, Maria, Vázquez Masedo, Gonzalo, Lozano Borbalas, Alicia, Cabrera Martín, María N., Esteve, Anna, Iglesias Moreno, María C., Vilajosana Altamis, Esther, Arribas Hortigüela, Lorena, Taberna Sanz, Miren, Pérez-Segura, Pedro, Mesía, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355730/
https://www.ncbi.nlm.nih.gov/pubmed/35936723
http://dx.doi.org/10.3389/fonc.2022.953020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355730/
https://www.ncbi.nlm.nih.gov/pubmed/35936723
http://dx.doi.org/10.3389/fonc.2022.953020

Ejemplares similares